MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 49 filers reported holding MERSANA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $9,557,000 | -44.0% | 955,709 | 0.0% | 18.05% | -31.3% |
| Q2 2018 | $17,069,000 | +13.2% | 955,709 | 0.0% | 26.27% | +51.6% |
| Q1 2018 | $15,072,000 | -4.0% | 955,709 | 0.0% | 17.33% | -16.9% |
| Q4 2017 | $15,702,000 | -5.0% | 955,709 | 0.0% | 20.86% | +26.0% |
| Q3 2017 | $16,524,000 | +23.8% | 955,709 | 0.0% | 16.55% | -3.0% |
| Q2 2017 | $13,351,000 | – | 955,709 | – | 17.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $28,503,484 | 2.94% |
| Logos Global Management LP | 2,800,000 | $9,212,000 | 1.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,100,000 | $3,619,000 | 1.12% |
| 5AM Venture Management, LLC | 1,305,000 | $4,293,450 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,000,000 | $3,290,000 | 1.02% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $2,975,042 | 0.93% |
| Sarissa Capital Management LP | 2,632,900 | $8,662,241 | 0.86% |
| DAFNA Capital Management LLC | 810,845 | $2,667,680 | 0.73% |
| Tri Locum Partners LP | 428,307 | $1,409,130 | 0.52% |
| Avidity Partners Management LP | 3,790,000 | $12,469,100 | 0.44% |